Day: March 11, 2026

FDA Grants Breakthrough Device Designation to MeMed BV Flex™ Capillary Blood

March 11, 2026

ANDOVER, Mass. and HAIFA, Israel, March 11, 2026 /PRNewswire/ — MeMed, a leader in advanced host-response diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to MeMed BV Flex™, a test designed to accurately distinguish between bacterial and viral infections based on the body’s immune response.

Olympus Launches Next-Generation Surgical Imaging Platform in U.S.

March 11, 2026

WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ — Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.

Blog

- March 11, 2026

FDA Grants Breakthrough Device Designation to MeMed BV Flex™ Capillary Blood

Olympus Launches Next-Generation Surgical Imaging Platform in U.S.